INOVOTION’s Olivier Baverey was recently interviewed by North Shore InnoVentures (NSIV), highlighting the company’s role in accelerating pre-clinical testing for Oncology Drug Discovery. To better serve its US market, Inovotion has opened a subsidiary in Boston in Feb 2018. Olivier and his colleagues support US-based Biotech/Pharma companies and academic research centers to dramatically improve their preclinical assays in oncology.
Give Olivier a call to learn more about how to dramatically improve your Drug Discovery productivity!
+1 (617) 337-7855 email@example.com